{"id":"https://openalex.org/W4406589614","doi":"https://doi.org/10.1080/10428194.2024.2445688","title":"The challenge of targeting key drivers of CLL and sequencing therapy in an era of experimental therapeutics","display_name":"The challenge of targeting key drivers of CLL and sequencing therapy in an era of experimental therapeutics","publication_year":2025,"publication_date":"2025-01-19","ids":{"openalex":"https://openalex.org/W4406589614","doi":"https://doi.org/10.1080/10428194.2024.2445688","pmid":"https://pubmed.ncbi.nlm.nih.gov/39827471"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2024.2445688","doi":"https://doi.org/10.1080/10428194.2024.2445688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2024.2445688","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082885518","display_name":"Britten K. Gordon","orcid":"https://orcid.org/0009-0006-8751-4435","observed_orcids":["https://orcid.org/0009-0006-8751-4435"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Britten K. Gordon","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University","Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University","Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA"],"raw_orcid":"https://orcid.org/0000-0002-3403-9144","affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014241029"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":null,"apc_paid":null,"fwci":0.142,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.17765668,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"66","issue":"5","first_page":"838","last_page":"846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.796999990940094},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.6859999895095825},{"id":"https://openalex.org/keywords/relapsed-refractory-cll","display_name":"relapsed/refractory CLL","score":0.9470000267028809},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8605571985244751},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7379746437072754},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.7241553068161011},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.6520529985427856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5386165976524353},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.5008010864257812},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4233076274394989},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4230802059173584},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.42044180631637573},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.41686689853668213},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38744065165519714},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.37090006470680237},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3319573402404785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31636208295822144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2627849578857422},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2328645884990692},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17950847744941711},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17473280429840088}],"mesh":[{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011947","descriptor_name":"Receptors, Antigen, B-Cell","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011947","descriptor_name":"Receptors, Antigen, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10428194.2024.2445688","doi":"https://doi.org/10.1080/10428194.2024.2445688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2024.2445688","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:39827471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39827471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W2018466312","https://openalex.org/W2067064694","https://openalex.org/W2071549499","https://openalex.org/W2075875145","https://openalex.org/W2107820445","https://openalex.org/W2172242534","https://openalex.org/W2192121806","https://openalex.org/W2233614027","https://openalex.org/W2558640761","https://openalex.org/W2781558580","https://openalex.org/W2787916641","https://openalex.org/W2792666902","https://openalex.org/W2902472954","https://openalex.org/W2902484351","https://openalex.org/W2952939985","https://openalex.org/W2955463869","https://openalex.org/W2964310707","https://openalex.org/W2972482801","https://openalex.org/W2973195462","https://openalex.org/W2974182987","https://openalex.org/W2991578543","https://openalex.org/W3012414877","https://openalex.org/W3012874730","https://openalex.org/W3014195933","https://openalex.org/W3029637120","https://openalex.org/W3082899459","https://openalex.org/W3094484041","https://openalex.org/W3138884962","https://openalex.org/W3176115030","https://openalex.org/W3185756680","https://openalex.org/W3196851008","https://openalex.org/W3211568627","https://openalex.org/W4213416073","https://openalex.org/W4223904810","https://openalex.org/W4224138250","https://openalex.org/W4282976889","https://openalex.org/W4284883545","https://openalex.org/W4285390717","https://openalex.org/W4288385981","https://openalex.org/W4308963956","https://openalex.org/W4309346784","https://openalex.org/W4310126604","https://openalex.org/W4311293040","https://openalex.org/W4376108172","https://openalex.org/W4382752021","https://openalex.org/W4383197912","https://openalex.org/W4386024134","https://openalex.org/W4388405671","https://openalex.org/W4388423164","https://openalex.org/W4389221984","https://openalex.org/W4389526874","https://openalex.org/W4390824558","https://openalex.org/W4392582468","https://openalex.org/W4396978251","https://openalex.org/W4399045499","https://openalex.org/W4399068242","https://openalex.org/W4401878485"],"related_works":["https://openalex.org/W4296793623","https://openalex.org/W4363626284","https://openalex.org/W4399054828","https://openalex.org/W4403622129","https://openalex.org/W3004696126","https://openalex.org/W3160398752","https://openalex.org/W4392590787","https://openalex.org/W3133529143","https://openalex.org/W4396574610","https://openalex.org/W2554770557"],"abstract_inverted_index":{"Treatment":[0],"of":[1,12,29,32,48,58,64,68,71,81,96],"chronic":[2],"lymphocytic":[3],"leukemia":[4],"(CLL)":[5],"has":[6,74],"been":[7],"revolutionized":[8],"with":[9],"the":[10,18,38,46,53,61,89,99,116],"introduction":[11],"small":[13],"molecule":[14],"inhibitors":[15],"targeting":[16],"both":[17,65,94],"B-cell":[19,25],"receptor":[20],"(BCR)":[21],"signaling":[22],"pathway":[23],"and":[24,37,55,101,109],"lymphoma-2":[26],"(BCL-2)":[27],"family":[28],"proteins.":[30],"Inhibitors":[31],"Bruton's":[33],"tyrosine":[34],"kinase":[35],"(BTK)":[36],"BH3":[39],"mimetic":[40],"venetoclax":[41],"are":[42],"bothcurrently":[43],"used":[44],"as":[45],"standard":[47],"care":[49],"for":[50,93,119],"patients":[51],"in":[52,79,98],"frontline":[54],"relapsed/refractory":[56],"setting":[57],"CLL.":[59,82,120],"With":[60],"clinical":[62],"success":[63],"these":[66,72,107],"classes":[67,95],"therapies,":[69],"sequencing":[70],"agents":[73,97],"become":[75],"a":[76],"major":[77],"challenge":[78],"treatment":[80,117],"In":[83],"this":[84],"review":[85],"we":[86,111],"will":[87],"discuss":[88],"current":[90],"data":[91],"available":[92],"front-line":[100],"relapsed/refractor":[102],"setting,":[103],"considerations":[104],"when":[105],"giving":[106],"agents,":[108],"how":[110],"can":[112],"continue":[113],"to":[114],"improve":[115],"landscape":[118]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-01-19T00:00:00"}